US markets
Biotech and healthcare company research across the US and Australia, covering drug development, medical devices, diagnostics and healthcare businesses. Explore articles on clinical milestones, regulatory announcements, commercial progress and financing. Coverage considers the distinction between a research milestone and an approved or commercially established product, alongside the risks and remaining steps described in each dated article.
1 result
Explore Australian marketsUS · Company Research
Zealand Pharma (CPH: ZEAL) shares fell more than 20% after new data raised concerns about its obesity drug partner program. The sell-off was linked to side effects and…
